CStone Pharmaceuticals
Chao Arthur Wu has over 25 years of experience in the pharmaceutical industry. Chao Arthur is currently serving as the Vice President and Head of Marketing at CStone Pharmaceuticals. Previously, they held the position of Vice President at Sperogenix, where they oversaw the China market commercial operations, including sales, marketing, and market innovation. Prior to that, they worked as the Franchise Head at Sanofi Genzyme, responsible for the commercial operation of the Rare Disease portfolio. Chao Arthur has also held various roles at Pfizer, including Marketing Head, Associate Marketing Director, Senior Marketing Manager, Country Brand Leader, and Strategy and New Product Planning Manager. Chao Arthur Wu began their pharmaceutical career as a Senior Product Manager at Pfizer Laboratorios and has also worked at Hutchison Pharmaceutical, Simcere Pharmaceutical Group, Pharmacia, and Roche.
Chao Arthur Wu obtained a Bachelor's degree in Biological Pharmaceutical from China Pharmaceutical University, where they studied from 1991 to 1995. Chao Arthur holds no additional certifications or specific information about their career history.
This person is not in any offices
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.